Clinical Trial Update: Noninvasive Screening for Early Evidence of Diabetes With SCOUT DS

View source ↗

Summary

A completed clinical trial evaluating VeraLight's SCOUT DS noninvasive screening technology for early evidence of Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SCOUT DS

Snippet

Sponsor: VeraLight, Inc. | Conditions: Type 2 Diabetes | Status: COMPLETED